These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 17059509)

  • 1. Review article: from 1906 to 2006--a century of major evolution of understanding of gastro-oesophageal reflux disease.
    Dent J
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1269-81. PubMed ID: 17059509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
    Frazzoni M; Manno M; De Micheli E; Savarino V
    Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
    Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
    Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the hiatus hernia in gastro-oesophageal reflux disease.
    Gordon C; Kang JY; Neild PJ; Maxwell JD
    Aliment Pharmacol Ther; 2004 Oct; 20(7):719-32. PubMed ID: 15379832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of gastro-oesophageal reflux disease.
    De Giorgi F; Palmiero M; Esposito I; Mosca F; Cuomo R
    Acta Otorhinolaryngol Ital; 2006 Oct; 26(5):241-6. PubMed ID: 17345925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ethiopathogenesis of gastroesophageal reflux disease].
    Lukás K; Marecek P
    Cas Lek Cesk; 2000 Aug; 139(15):455-9. PubMed ID: 22666924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review: geographical and ethnic differences in gastro-oesophageal reflux disease.
    Kang JY
    Aliment Pharmacol Ther; 2004 Oct; 20(7):705-17. PubMed ID: 15379831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient lower oesophageal sphincter relaxations--a pharmacological target for gastro-oesophageal reflux disease?
    Hirsch DP; Tytgat GN; Boeckxstaens GE
    Aliment Pharmacol Ther; 2002 Jan; 16(1):17-26. PubMed ID: 11856074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical treatment of gastro-oesophageal reflux disease.
    De Giorgi F; Savarese MF; Atteo E; Leone CA; Cuomo R
    Acta Otorhinolaryngol Ital; 2006 Oct; 26(5):276-80. PubMed ID: 17345932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine management of gastro-oesophageal reflux disease by gastroenterologists in France: a prospective observational study.
    Bretagne JF; Rey JF; Caekaert A; Barthélemy P
    Dig Liver Dis; 2005 Aug; 37(8):566-70. PubMed ID: 15886080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
    Fujiwara Y; Higuchi K; Nebiki H; Chono S; Uno H; Kitada K; Satoh H; Nakagawa K; Kobayashi K; Tominaga K; Watanabe T; Oshitani N; Arakawa T
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)--a reappraisal 10 years on.
    Pace F; Bollani S; Molteni P; Bianchi Porro G
    Dig Liver Dis; 2004 Feb; 36(2):111-5. PubMed ID: 15002817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.
    Wada T; Sasaki M; Kataoka H; Tanida S; Itoh K; Ogasawara N; Oshima T; Togawa S; Kubota E; Yamada T; Mori Y; Fujita F; Ohara H; Nakao H; Sobue S; Joh T; Itoh M
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():2-9. PubMed ID: 15943840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
    Miner PB
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: gastro-oesophageal reflux disease -- how wide is its span?
    Talley NJ
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():27-37; discussion 38-9. PubMed ID: 15456461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-oesophageal acid suppression in complicated gastro-oesophageal reflux disease: esomeprazole versus lansoprazole.
    Frazzoni M; Manno M; De Micheli E; Savarino V
    Dig Liver Dis; 2006 Feb; 38(2):85-90. PubMed ID: 16289976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-oesophageal distribution and perception of acid reflux in patients with non-erosive gastro-oesophageal reflux disease.
    Cicala M; Emerenziani S; Caviglia R; Guarino MP; Vavassori P; Ribolsi M; Carotti S; Petitti T; Pallone F
    Aliment Pharmacol Ther; 2003 Sep; 18(6):605-13. PubMed ID: 12969087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of gastro-oesophageal reflux disease with rabeprazole in primary and secondary care: does Helicobacter pylori infection affect proton pump inhibitor effectiveness?
    Wit NJ; Boer WA; Geldof H; Hazelhoff B; Bergmans P; Tytgat GN; Smout AJ
    Aliment Pharmacol Ther; 2004 Aug; 20(4):451-8. PubMed ID: 15298640
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.